Deverra Therapeutics logo

Deverra Therapeutics

Cell Therapies for All

14 employees · est. 2020 · Seattle, United States

VS
LigniLabs GmbH logo

LigniLabs GmbH

Pioneers in biobased solutions.

9 employees · est. 2022 · Mainz, Germany

Deverra Therapeutics is the older company (2020 vs 2022); Deverra Therapeutics is the larger of the two.

Side-by-Side Comparison

Deverra Therapeutics LigniLabs GmbH
Founded
2020 older 2022
Headquarters
Seattle, United States Mainz, Germany
Employees
14 larger 9
Industry
Biotechnology Not tracked yet
Funding Stage
Grant Seed
Total Funding
$3.58M $850.00K
Funding Rounds
2 2
Services
Not tracked yet Development of bio-based microencapsulation solutions, Commercialization of lignin-based applications
Target Customers
Not tracked yet Pharmaceutical companies, Cosmetic manufacturers, Food industry, Agricultural sector
Taxonomy
Cell Therapies, Clinical Stage, Allogeneic Cellular Immunotherapies, Stem Cell Expansion, Directed Differentiation Platform, Cancer Treatment, Infectious Diseases Treatment, Proprietary Technology, Clinical Trials, Immunotherapy, Fred Hutchinson Cancer Research Center, Immune Cell Therapy, Therapeutic Development, Patient-centric Treatment Biobased Solutions, Encapsulation Technology, Lignin Modification, Nanotechnology, Microtechnology, Active Ingredient Encapsulation, Sustainable Materials, Plant Disease Treatment, Agrotech, Life Sciences, Bio-based Flame Retardants, Materials Science, Plant Protection
Website
deverratx.com lignilabs.de
Deverra Therapeutics logo

About Deverra Therapeutics

Deverra Therapeutics is a biotechnology startup founded in 2019 with a primary focus on developing allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company holds an exclusive license to a proprietary stem cell expansion a...

LigniLabs GmbH logo

About LigniLabs GmbH

LigniLabs GmbH, founded in 2022 and headquartered in Germany, positions itself as "Pioneers in biobased solutions." This innovative startup focuses on exploiting its proprietary micro- and nanotechnology platform to revolutionize the bio-based encapsulation of active ingredients using lignin, a natu...

We will tell you when either one moves

BounceWatch watches Deverra Therapeutics and LigniLabs GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Deverra Therapeutics and LigniLabs GmbH — by email.

Frequently Asked Questions

Deverra Therapeutics — Cell Therapies for All. LigniLabs GmbH — Pioneers in biobased solutions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Deverra Therapeutics has raised $3.58M while LigniLabs GmbH has raised $850.00K.
Deverra Therapeutics and LigniLabs GmbH operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Deverra Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Deverra Therapeutics on 12 Sep 2024, and LigniLabs GmbH on 12 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes